Remove Aneurysm Remove Cholesterol Remove Circulation
article thumbnail

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G?Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease

Journal of the American Heart Association

In apolipoprotein E−/−and wild‐type mice, BAR502, a dual GPBAR1/FXR agonist, alone or in combination with atorvastatin, reduced cholesterol and low‐density lipoprotein plasma levels, mitigated the development of liver steatosis and aortic plaque formation, and shifted the polarization of circulating leukocytes toward an anti‐inflammatory phenotype.

Aortic 40
article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3 2019 Sep 10;140(11):e649-e650] [published correction appears in Circulation. 2020 Jan 28;141(4):e60] [published correction appears in Circulation.

article thumbnail

Society for Vascular Surgery Launches Campaign to Help People Maintain Vascular Health

DAIC

Vascular conditions can slow circulation and impact the way the body functions. Risk factors for vascular disease include having diabetes, use or history of tobacco products, high cholesterol, and/or high blood pressure. More than 8 in 10 (85%) people are not familiar with the role of vascular surgeons.